Literature DB >> 17923239

Identifying small molecule inhibitors of eukaryotic translation initiation.

Regina Cencic1, Francis Robert, Jerry Pelletier.   

Abstract

In eukaryotes, translation initiation is rate-limiting with much regulation exerted at the ribosome recruitment and ternary complex (eIF2.GTP.Met-tRNA(i)(Met)) formation steps. Although small molecule inhibitors have been extremely useful for chemically dissecting translation, there is a dearth of compounds available to study the initiation phase in vitro and in vivo. In this chapter, we describe reverse and forward chemical genetic screens developed to identify new inhibitors of translation. The ability to manipulate cell extracts biochemically, and to compare the activity of small molecules on translation of mRNA templates that differ in their factor requirements for ribosome recruitment, facilitates identification of the relevant target.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17923239     DOI: 10.1016/S0076-6879(07)31013-6

Source DB:  PubMed          Journal:  Methods Enzymol        ISSN: 0076-6879            Impact factor:   1.600


  9 in total

Review 1.  Leveraging a large microbial strain collection for natural product discovery.

Authors:  Andrew D Steele; Christiana N Teijaro; Dong Yang; Ben Shen
Journal:  J Biol Chem       Date:  2019-09-30       Impact factor: 5.157

2.  A collection of caged compounds for probing roles of local translation in neurobiology.

Authors:  Oleg Sadovski; Anna S I Jaikaran; Subhas Samanta; Marc R Fabian; Ryan J O Dowling; Nahum Sonenberg; G Andrew Woolley
Journal:  Bioorg Med Chem       Date:  2010-04-07       Impact factor: 3.641

3.  A harmine-derived beta-carboline displays anti-cancer effects in vitro by targeting protein synthesis.

Authors:  Annelise Carvalho; Jennifer Chu; Céline Meinguet; Robert Kiss; Guy Vandenbussche; Bernard Masereel; Johan Wouters; Alexander Kornienko; Jerry Pelletier; Véronique Mathieu
Journal:  Eur J Pharmacol       Date:  2017-03-18       Impact factor: 4.432

4.  Blocking UV-induced eIF2alpha phosphorylation with small molecule inhibitors of GCN2.

Authors:  Francis Robert; Chris Williams; Yifei Yan; Elizabeth Donohue; Regina Cencic; Stephen K Burley; Jerry Pelletier
Journal:  Chem Biol Drug Des       Date:  2009-07       Impact factor: 2.817

5.  Uncoupling stress granule assembly and translation initiation inhibition.

Authors:  Sophie Mokas; John R Mills; Cristina Garreau; Marie-Josée Fournier; Francis Robert; Prabhat Arya; Randal J Kaufman; Jerry Pelletier; Rachid Mazroui
Journal:  Mol Biol Cell       Date:  2009-04-15       Impact factor: 4.138

6.  A cellular response linking eIF4AI activity to eIF4AII transcription.

Authors:  Gabriela Galicia-Vázquez; Regina Cencic; Francis Robert; Aouod Quang Agenor; Jerry Pelletier
Journal:  RNA       Date:  2012-05-15       Impact factor: 4.942

7.  5,10b-Ethanophenanthridine amaryllidaceae alkaloids inspire the discovery of novel bicyclic ring systems with activity against drug resistant cancer cells.

Authors:  Sean Henry; Ria Kidner; Mary R Reisenauer; Igor V Magedov; Robert Kiss; Véronique Mathieu; Florence Lefranc; Ramesh Dasari; Antonio Evidente; Xiaojie Yu; Xiuye Ma; Alexander Pertsemlidis; Regina Cencic; Jerry Pelletier; David A Cavazos; Andrew J Brenner; Alexander V Aksenov; Snezna Rogelj; Alexander Kornienko; Liliya V Frolova
Journal:  Eur J Med Chem       Date:  2016-05-06       Impact factor: 6.514

8.  Murine norovirus 1 (MNV1) replication induces translational control of the host by regulating eIF4E activity during infection.

Authors:  Elizabeth Royall; Nicole Doyle; Azimah Abdul-Wahab; Ed Emmott; Simon J Morley; Ian Goodfellow; Lisa O Roberts; Nicolas Locker
Journal:  J Biol Chem       Date:  2015-01-05       Impact factor: 5.157

9.  A comparative study of small molecules targeting eIF4A.

Authors:  Sai Kiran Naineni; Rayelle Itoua Maïga; Regina Cencic; Andrea A Putnam; Luis A Amador; Abimael D Rodriguez; Eckhard Jankowsky; Jerry Pelletier
Journal:  RNA       Date:  2020-02-03       Impact factor: 4.942

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.